Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-07-18 07:52 |
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the …
|
Dutch | 203.1 KB | ||
| 2023-07-18 07:52 |
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the …
|
English | 198.1 KB | ||
| 2023-06-01 07:31 |
Pharming announces sale of priority review voucher
|
Dutch | 201.1 KB | ||
| 2023-06-01 07:31 |
Pharming announces sale of priority review voucher
|
English | 229.7 KB | ||
| 2023-05-19 07:46 |
Pharming Group reports on results of the 2023 Annual General Meeting of Shareho…
|
English | 202.6 KB | ||
| 2023-05-19 07:46 |
Pharming Group reports on results of the 2023 Annual General Meeting of Shareho…
|
English | 203.8 KB | ||
| 2023-05-11 07:51 |
Pharming Group reports financial results for the first quarter of 2023
|
English | 427.7 KB | ||
| 2023-05-11 07:51 |
Pharming Group reports financial results for the first quarter of 2023
|
English | 419.5 KB | ||
| 2023-04-11 07:55 |
Pharming announces the first commercial shipments of Joenja® (leniolisib) to pa…
|
English | 255.6 KB | ||
| 2023-04-11 07:55 |
Pharming announces the first commercial shipments of Joenja® (leniolisib) to pa…
|
English | 259.4 KB | ||
| 2023-04-05 09:08 |
Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
|
English | 192.6 KB | ||
| 2023-04-05 09:08 |
Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
|
English | 199.3 KB | ||
| 2023-04-05 09:08 |
Pharming Group convenes the Annual General Meeting of Shareholders 2023
|
English | 204.4 KB | ||
| 2023-04-05 09:08 |
Pharming Group convenes the Annual General Meeting of Shareholders 2023
|
English | 203.9 KB | ||
| 2023-04-05 07:01 | English | 9.9 MB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
